Authors: Takemasa, A Yorioka, N Oda, H Amimoto, D Ito, T Yamakido, M

Citation: A. Takemasa et al., Mechanism of increased serum soluble interleukin-2 receptor levels in patients on continuous ambulatory peritoneal dialysis, SC J UROL N, 35(2), 2001, pp. 141-146

Authors: Takemasa, A Yorioka, N Ueda, C Amimoto, D Taniguchi, Y Yamakido, M

Citation: A. Takemasa et al., Stimulation of tumour necrosis factor-alpha production by recombinant human erythropoietin may contribute to failure of therapy, SC J UROL N, 34(2), 2000, pp. 131-135

Authors: Yorioka, N Taniguchi, Y Amimoto, D Ogata, S Sakikubo, E Yamakido, M Naito, T Shimamoto, F

Citation: N. Yorioka et al., Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, CLIN NEPHR, 52(5), 1999, pp. 293-296

Authors: Yorioka, N Taniguchi, Y Amimoto, D Miyata, H Yamakido, M Taguchi, T

Citation: N. Yorioka et al., Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophilcytoplasmic antibody-associated nephritis, AM J NEPHR, 19(4), 1999, pp. 527-529

Authors: Yorioka, N Taniguchi, Y Okushin, S Amimoto, D Kataoka, K Taguchi, T

Citation: N. Yorioka et al., Classic polyarteritis nodosa associated with renal amyloidosis, NEPHRON, 82(1), 1999, pp. 93-94

Authors: Taniguchi, Y Yorioka, N Kumagai, J Katsutani, M Kuratsune, M Amimoto, D Yamakido, M

Citation: Y. Taniguchi et al., Interleukin-6 localization and the prognosis of IgA nephropathy, NEPHRON, 81(1), 1999, pp. 94-98